Definition

A medication used in the treatment of adrenocortical carcinoma, a rare type of cancer that arises from the adrenal cortex. Mitotane is an adrenal corticosteroid inhibitor that disrupts the adrenal cortex's ability to produce cortisol and other steroid hormones, thereby interfering with the growth of adrenocortical carcinoma cells.